# OnCo record sthlm3-mri (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/sthlm3-mri/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "sthlm3-mri", "NCT03377881" ;
  schema:name "STHLM3-MRI (Stockholm3 and MRI-targeted biopsy in prostate cancer screening)"@en ;
  schema:alternateName "STHLM3MR-2"@en, "STHLM3 MR Phase 2"@en, "Stockholm3-MRI"@en ;
  schema:description "A Stockholm trial that invited men from the general population for prostate testing and asked whether using an MRI scan to decide who needs a biopsy finds as many important cancers as biopsying everyone with a raised PSA. It did, and it found about a third as many harmless cancers."@en ;
  schema:url <https://onco.cc/trials/sthlm3-mri/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT03377881>, <https://doi.org/10.1056/NEJMoa2100852>, <https://doi.org/10.7326/ANNALS-25-04753> ;
  onco:status "positive" ;
  onco:phase "not-applicable" ;
  schema:startDate "2018-04-04" ;
  onco:cancers <https://onco.cc/cancers/prostate/> ;
  onco:sections <https://onco.cc/fronts/early-detection/> ;
  onco:technologies <https://onco.cc/technologies/prostate-screening-psa-mri/>, <https://onco.cc/technologies/mp-mri/> ;
  onco:institutions <https://onco.cc/institutions/karolinska/>, <https://onco.cc/institutions/capio-st-goran/> ;
  onco:terms <https://onco.cc/terms/psa/>, <https://onco.cc/terms/overdiagnosis/> ;
  onco:people <https://onco.cc/people/martin-eklund/>, <https://onco.cc/people/henrik-gronberg/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-early-detection/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-eklund-sthlm3-mri-nejm-2021/> .